Hmm..."GLOBAL Clinical Trial".....could this mean enrolling participants in countries other than China? If so, that could result in recognition of ENMD-2076's effectiveness in other countries, with possible approval to market the drug in them....Just dreamin'......
"In parallel with the advancement of our ENMD-2076 program," Dr. Ren further continued, "we are also evaluating additional drug candidates to add to our pipeline, with emphasis on compounds that have the potential for gaining widespread market acceptance globally or in China and for which development can be carried out cost-effectively under our global drug development strategy."
To me this reads: CFI 400945 is ours!
This is what will make the splash! Exciting times ahead of us for ENMD!